Pulse Biosciences, Inc. financial data

Symbol
PLSE on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3957 Point Eden Way, Hayward, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Electroblate, Inc. (to 11/13/2014)
Latest financial report
10-Q - Q2 2024 - Aug 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 690 % -28.8%
Quick Ratio 54.7 % +43%
Debt-to-equity 34.4 % -92.8%
Return On Equity -110 % +68.4%
Return On Assets -82 % -35.6%
Operating Margin 442K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61.3M shares +11.6%
Common Stock, Shares, Outstanding 55.2M shares +0.83%
Entity Public Float 124M USD +421%
Common Stock, Value, Issued 55K USD 0%
Weighted Average Number of Shares Outstanding, Basic 57.2M shares +24.1%
Weighted Average Number of Shares Outstanding, Diluted 37.2M shares +25.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Cost of Revenue 0 USD -100%
Research and Development Expense 29.2M USD +38.3%
General and Administrative Expense 16.9M USD +30.6%
Costs and Expenses 46.1M USD -0.91%
Operating Income (Loss) -46.1M USD +0.93%
Nonoperating Income (Expense) 2.11M USD +8.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -44M USD +6.24%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -44M USD +6.24%
Earnings Per Share, Basic -0.78 USD/shares +33.9%
Earnings Per Share, Diluted -0.49 USD/shares -2.08%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.2M USD -55.4%
Cash, Cash Equivalents, and Short-term Investments 14.8M USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 0 USD -100%
Assets, Current 27.2M USD -54.6%
Property, Plant and Equipment, Net 1.31M USD -25.2%
Operating Lease, Right-of-Use Asset 6.82M USD -11.1%
Goodwill 2.79M USD 0%
Other Assets, Noncurrent 714K USD +95.6%
Assets 40.4M USD -45.9%
Accounts Payable, Current 1.64M USD -8.75%
Employee-related Liabilities, Current 2.68M USD +26.1%
Accrued Liabilities, Current 3.18M USD +11.8%
Contract with Customer, Liability, Current 4K USD -75%
Liabilities, Current 5.96M USD +6.22%
Operating Lease, Liability, Noncurrent 7.5M USD -13.3%
Liabilities 13.5M USD -5.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -358M USD -14%
Stockholders' Equity Attributable to Parent 27M USD -55.4%
Liabilities and Equity 40.4M USD -45.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.78M USD -48.9%
Net Cash Provided by (Used in) Financing Activities 305K USD
Net Cash Provided by (Used in) Investing Activities -39K USD +86%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 55.2M shares +0.83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.48M USD -34.6%
Deferred Tax Assets, Valuation Allowance 87.9M USD +10.1%
Deferred Tax Assets, Gross 89.5M USD +8.48%
Operating Lease, Liability 8.64M USD -10.1%
Depreciation 539K USD -18.9%
Payments to Acquire Property, Plant, and Equipment 5K USD -87.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -44M USD +6.24%
Lessee, Operating Lease, Liability, to be Paid 11.2M USD -14.4%
Property, Plant and Equipment, Gross 5.05M USD +1.51%
Operating Lease, Liability, Current 1.15M USD +17.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.05M USD +3.49%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.98M USD +3.51%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.54M USD -26.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.12M USD +3.47%
Deferred Tax Assets, Operating Loss Carryforwards 61.1M USD +8.19%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 10.2M USD +14%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.12M USD +3.47%
Operating Lease, Payments 469K USD +3.53%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 167K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 1.65M USD -39.5%
Share-based Payment Arrangement, Expense 8.95M USD +155%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%